Tylosin 20%
Key Features
Properties
- Antibiotic formulation containing Tylosin Tartrate 20%.
- Tylosin belongs to the macrolide group of antibiotics.
- Has a bacteriostatic mode of action.
- Acts by binding to the 50S ribosomal subunit, inhibiting bacterial protein synthesis.
- Provides activity against susceptible bacterial organisms and Mycoplasma.
- Active against susceptible aerobic and anaerobic bacteria as stated in the supplied product information.
Benefits
- Provides antimicrobial activity against a range of susceptible bacterial pathogens.
- Effective against susceptible Staphylococcus and Streptococcus.
- Provides activity against susceptible Brucella, Pasteurella, Clostridia and Klebsiella.
- Active against susceptible Haemophilus, Corynebacterium, E. coli and Salmonella.
- Provides activity against susceptible Mycoplasma.
- Also indicated against susceptible organisms associated with spirochetosis, actinomycosis and rickettsial
Ingredients
Active Ingredient
- Tylosin Tartrate — 20%
Packaging
Pack Size:
- 25 g sachet
- 100 g sachet
- 1 kg sachet
Recommended Usage
Indications
For the treatment of infections caused by susceptible organisms, including:
- Staphylococcus
- β-haemolytic Streptococcus
- Non-haemolytic Streptococcus
- Brucella
- Pasteurella
- Clostridia
- Klebsiella
- Haemophilus
- Corynebacterium
- E. coli
- Salmonella
- Mycoplasma
- Actinomyces
- Rickettsia
Dosage & Administration
Not specified in the supplied product information.
Withdrawal Period
After the last dose:
- Meat: 5 days
- Eggs: 5 days
Storage Conditions
Store below 30°C in a dry place away from direct sunlight.
Keep out of reach of children.
Disposal
Dispose of any unused veterinary medicinal product in accordance with local regulatory requirements.
Key Features
Properties
- Antibiotic formulation containing Tylosin Tartrate 20%.
- Tylosin belongs to the macrolide group of antibiotics.
- Has a bacteriostatic mode of action.
- Acts by binding to the 50S ribosomal subunit, inhibiting bacterial protein synthesis.
- Provides activity against susceptible bacterial organisms and Mycoplasma.
- Active against susceptible aerobic and anaerobic bacteria as stated in the supplied product information.
Benefits
- Provides antimicrobial activity against a range of susceptible bacterial pathogens.
- Effective against susceptible Staphylococcus and Streptococcus.
- Provides activity against susceptible Brucella, Pasteurella, Clostridia and Klebsiella.
- Active against susceptible Haemophilus, Corynebacterium, E. coli and Salmonella.
- Provides activity against susceptible Mycoplasma.
- Also indicated against susceptible organisms associated with spirochetosis, actinomycosis and rickettsial
Ingredients
Active Ingredient
- Tylosin Tartrate — 20%
Packaging
Pack Size:
- 25 g sachet
- 100 g sachet
- 1 kg sachet
Recommended Usage
Indications
For the treatment of infections caused by susceptible organisms, including:
- Staphylococcus
- β-haemolytic Streptococcus
- Non-haemolytic Streptococcus
- Brucella
- Pasteurella
- Clostridia
- Klebsiella
- Haemophilus
- Corynebacterium
- E. coli
- Salmonella
- Mycoplasma
- Actinomyces
- Rickettsia
Dosage & Administration
Not specified in the supplied product information.
Withdrawal Period
After the last dose:
- Meat: 5 days
- Eggs: 5 days
Storage Conditions
Store below 30°C in a dry place away from direct sunlight.
Keep out of reach of children.
Disposal
Dispose of any unused veterinary medicinal product in accordance with local regulatory requirements.
Quality Assured
Reliable animal health and nutrition support
Specialist Formulation
Developed for targeted product performance
Trusted Support
Professional help for partners and enquiries
TYLOSIN 20% is a bacteriostatic antibiotic formulation containing Tylosin Tartrate, an antibiotic belonging to the macrolide group. It provides activity against a range of susceptible bacterial organisms and Mycoplasma.
Tylosin acts by binding to the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. It is indicated for the treatment of infections caused by organisms susceptible to Tylosin Tartrate.
Pack Size: 25 g, 100 g and 1 kg Sachets
Benefits
- Contains Tylosin Tartrate 20%.
- Macrolide antibiotic with bacteriostatic activity.
- Acts by inhibiting bacterial protein synthesis.
- Provides activity against a range of susceptible bacterial pathogens.
- Effective against susceptible Mycoplasma.
- Provides activity against susceptible organisms associated with spirochetosis, actinomycosis and rickettsial infections.
Indications
Tylosin Tartrate is indicated for infections caused by susceptible organisms, including:
- Staphylococcus
- β-haemolytic Streptococcus
- Non-haemolytic Streptococcus
- Brucella
- Pasteurella
- Clostridia
- Klebsiella
- Haemophilus
- Corynebacterium
- E. coli
- Salmonella
- Mycoplasma
- Actinomyces
- Rickettsia
Withdrawal Period
After the last dose:
- Meat: 5 days
- Eggs: 5 days
Storage Conditions
Store below 30°C in a dry place away from direct sunlight.
Keep out of reach of children.
Disposal
Any unused veterinary medicinal product should be disposed of in accordance with local regulatory requirements.
Pack Sizes
- 25 g sachet
- 100 g sachet
- 1 kg sachet





